43% is the present pregnant women living with hiv antiretroviral therapy coverage for pmtct value in Myanmar, reflecting an increase of 21% (95.5%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Myanmar
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Myanmar
Male unintentional poisoning
1.2
-0.0
(2021)
Female wasting in children
5.8%
-0.4%
(2018)
Female prevalence of HIV
0.4%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar158
+intl dollar26
(2022)
Birth registration
81.3%
+8.9%
(2016)
Contraceptive modern method prevalence
51.3%
+12.9%
(2016)
Myanmar PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 43% | +21% |
| 2021 | 22% | -59% |
| 2020 | 81% | -5% |
| 2019 | 86% | 0% |
| 2018 | 86% | +4% |
| 2017 | 82% | +1% |
| 2016 | 81% | +7% |
| 2015 | 74% | +3% |
| 2014 | 71% | +10% |
| 2013 | 61% | +4% |
| 2012 | 57% | +7% |
| 2011 | 50% | +9% |
| 2010 | 41% | +2% |
| 2009 | 39% | +9% |
| 2008 | 30% | +5% |
| 2007 | 25% | +6% |
| 2006 | 19% | +8% |
| 2005 | 11% | +3% |
| 2004 | 8% | +4% |
| 2003 | 4% | +4% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |